HOME >> BIOLOGY >> NEWS
Enzyme inhibitors block replication of SARS virus

The study was conducted by researchers from Scripps Research; the Genomics Research Center, Academia Sinica, Taiwan; and the National Taiwan University. It is being published today in the journal Chemistry and Biology (Vol. 13, No. 3).

Chi-Huey Wong is currently the Ernest W. Hahn Chair in Chemistry at the Skaggs Institute of Chemical Biology and directs the Scripps Research lab heading the study. He said the new finding is an important step in developing a possible drug treatment against SARS.

"We have been working on the problem of SARS since the epidemic started in 2003," Wong said. "This new class of inhibitors represents the most potent SARS virus protease inhibitors known today."

The path to today's research finding has taken several years. In 2002, Severe Acute Respiratory Syndrome (SARS) emerged in rural China and eventually spread to 32 countries, according to the World Health Organization. SARS is caused by a ring-shaped virus, known as a coronavirus. The SARS coronavirus is suspected of originating in animal populations before migrating to humans. Hardest-hit were six Asian nations. By the time the epidemic had been controlled in 2003, the disease infected more than 8,000 people, causing 800 deaths. There is no current effective treatment or vaccine.

Researchers have known since 2003 that a site on the virus is responsible for mediating proteases that allow the virus to replicate. Since then researchers have been testing protease inhibitors to lock up this site, known as SARS 3CLpro, and effectively stop the virus from infecting additional cells in the body.

In 2004, Wong's lab discovered that Lopinavir, a protease inhibitor of HIV also known as TL3, also served as weak inhibitor of the SARS 3CLpro site (PNAS, 101, 10012-10017). Since then, members of Wong's group further studied Lopinavir and are preparing it for clinical trials against SARS.

Researchers in Wong's lab at Scripps Research and in Taiwan ha
'"/>

Contact: Keith McKeown
kmckeown@scripps.edu
858-784-8134
Scripps Research Institute
28-Mar-2006


Page: 1 2

Related biology news :

1. Enzyme discovery sheds light on vitamin D
2. Enzyme delivered in smaller package protects cells from radiation damage
3. Enzyme Engineering XIX
4. Enzyme inhibitor produces stable disease in patients with advanced solid cell cancers
5. Enzyme shreds Alzheimers protein
6. Enzyme defect leads to hyperinsulinism
7. Eat less, weigh more? Enzyme makes lean mice susceptible to dietary fat
8. Enzyme crystal structure reveals unexpected genome repair functions
9. Enzyme may be target for new anti-inflammatory compounds
10. Enzyme action creates protein linked to Alzheimers disease
11. Enzyme deficiency may contribute to liver cancer, Mount Sinai research indicates

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/10/2018)... ... 2018 , ... Nanomedical Diagnostics , leading producer of graphene biosensors ... Drive, Suite 100, effectively tripling its space from 5,200 to 16,500 square feet. ... sales of our drug discovery platforms. We’re in the great position of having to ...
(Date:12/5/2018)... , ... December 05, 2018 , ... ... Annual AANS/CNS Summit in Nashville, TN, from December 6-9, 2018 at booth #312. ... platform that seamlessly integrates throughout the treatment continuum – from the consultation, to ...
(Date:12/5/2018)... , ... December 03, 2018 , ... ... Aesthetics , an emerging leader in the distribution and marketing of cutting-edge aesthetic ... growth, projecting $20MM in sales for 2018. Cartessa’s success can be attributed ...
Breaking Biology News(10 mins):
(Date:11/13/2018)... SAN DIEGO (PRWEB) , ... November 12, 2018 ... ... medical device to reduce stethoscope contamination that two large U.S. studies, published last ... appearing in the American Journal of Infection Control (AJIC) conclude that stethoscopes are ...
(Date:11/13/2018)... ... November 13, 2018 , ... Aditya Humad, Managing Partner of ... that asserts it is still trending upward with growing valuations based on a ... market consolidation, pricing pressure and increased competition as reasons often cited by institutional ...
(Date:11/13/2018)... ... 13, 2018 , ... Sharon Kleyne, founder and new water ... Oregon believes in the power of talk radio education Power of Water® research ... Power of Water® on talk radio every week with the “Sharon Kleyne Hour”, ...
(Date:11/9/2018)... FRANCISCO (PRWEB) , ... November 08, 2018 , ... ... of Dr. Pablo Valenzuela, PhD, co-Founder, Chief Executive Officer and President of Andes ... doctors from around the world, Dr. Valenzuela brings to uBiome expertise on the ...
Breaking Biology Technology:
Cached News: